New injection could offer Long-Term relief for back pain sufferers
Symptom relief
Recruiting now
This study tests a single injection of a cell therapy (Rexlemestrocel-L) combined with hyaluronic acid into the spine for people with moderate to severe chronic low back pain caused by degenerative disc disease. The goal is to see if it reduces pain over 12 months compared to a c…
Phase: PHASE3 • Sponsor: Mesoblast, Ltd. • Aim: Symptom relief
Last updated May 11, 2026 20:41 UTC